Ven­ter quick­ly grabs the reins back at Hu­man Longevi­ty; Pe­ter Thiel backs up­start ChemomAb

→ Af­ter less than a year in the role, Cyn­thia Collins is out at Hu­man Longevi­ty. J. Craig Ven­ter’s high-fly­ing an­ti-ag­ing start­up re­cruit­ed the for­mer GE ex­ec­u­tive last Jan­u­ary, when founder Ven­ter hand­ed the CEO reins over for the first time. Ven­ter on­ly loos­ened his grip on the wheel, con­tin­u­ing lead­er­ship as ex­ec­u­tive chair­man and stay­ing on board in a dai­ly role lead­ing the com­pa­ny’s sci­en­tif­ic strat­e­gy and di­rec­tion. Collins was for­mer­ly CEO of GE Health­care, and when she came to HLI she brought a slew of top ex­ec­u­tives with her. Now, Ven­ter is tak­ing back over as CEO. The com­pa­ny gave no rea­son for the abrupt lead­er­ship change. Last year, HLI al­so lost its chief da­ta sci­en­tist Franz Och (the chief ar­chi­tect of Google Trans­late), who left the role to join Grail.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER